High dosage metolazone in chronic renal failure

H J Dargie, M E Allison, A C Kennedy, M J Gray, H J Dargie, M E Allison, A C Kennedy, M J Gray

Abstract

Metolazone is a modified quinazolinesulphonamide and in a dose of between 4 and 7.5 mg is an effective diuretic in man with normal renal function. Fourteen patients with non-oedematous stable chronic renal failure (creatinine clearance ranging from 1.2 to 12 ml/min) were given metolazone in doses ranging from 20-150 mg. A noticeable increase in urine flow and sodium excretion occurred, free water clearance increased, and there was a small but significant increase in potassium excretion. No side effects were noted.

References

    1. JAMA. 1966 Mar 21;195(12):1066-9
    1. Ann N Y Acad Sci. 1966 Nov 22;139(2):453-65
    1. Ann N Y Acad Sci. 1966 Nov 22;139(2):471-80
    1. Ann Intern Med. 1968 Aug;69(2):249-61
    1. Acta Med Scand. 1968 Dec;184(6):473-9
    1. Arch Int Pharmacodyn Ther. 1969 Jan;177(1):71-87
    1. N Y State J Med. 1971 Mar 1;71(5):566-9
    1. Clin Sci. 1971 Sep;41(3):171-87
    1. Kidney Int. 1972 Mar;1(3):169-81
    1. Circulation. 1961 Feb;23:200-10
    1. Ann Intern Med. 1965 Jan;62:15-29
    1. Proc Soc Exp Biol Med. 1950 May;74(1):148-51

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren